News | August 03, 2010

New Jersey Medical Center Receives Award for Use of Therapeutic Cooling

August 3, 2010 — St. Joseph’s Regional Medical Center (SJRMC) in Paterson, N.J., received the Chain of Survival Award from the Sudden Cardiac Arrest Association and accolades from New Jersey Gov. Chris Christie for its trendsetting work in using prehospital therapeutic cooling of cardiac arrest patients.

Therapeutic hypothermia is used to stabilize cardiac arrest patients whose hearts have stopped and have been restarted. The St. Joseph’s MICU team initiates this cooling procedure at the scene for patients who are being brought to the medical center, and it is continued for 24-36 hours in the hospital setting.

The medical center, a state-designated trauma center, was the first hospital in the state to implement therapeutic cooling by paramedics and physicians in the prehospital. Therapeutic cooling continues in the emergency department and extends to the inpatient setting at the regional medical center. The induced hypothermia helps buy more time for physicians treating these patients.

“We are setting the standard in emergency critical care,” explained Mark Rosenberg, M.D., chairman of emergency medicine at St. Joseph’s Regional Medical Center. “By bringing therapeutic cooling to a patient at the scene of a cardiac arrest, even before transport to the hospital begins, lives will continue to be saved. It is our mission to provide our patients with innovative and successful protocols in life-saving care.”

The induced hypothermia helps buy more time for physicians treating these patients.

“Our emergency services team has been able to successfully bring back patients who were clinically dead, including those who have not had a pulse for 10 minutes,” Rosenberg said. “The chance of success depends on many factors, including the quality of care in the field. Once we get the heart started, we also resuscitate the brain, which involves putting the patient into a controlled coma and using therapeutic hypothermia. Most hospitals don’t do that.”

The Resuscitation Center at St. Joseph’s is a comprehensive center dedicated to the continuum of care of cardio pulmonary resuscitation. The center utilizes therapeutic hypothermia both prehospital and during a patient’s visit, prehospital electrocardiograms (ECGs) and telemetry diagnosis, impedance threshold devices to improve ventilation, automatic chest compression devices, as well as a primary angioplasty program for ST-elevated myocardial infarction (STEMI) patients.

For more information: StJosephsHealth.org

Related Content

Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Ra Medical Systems Granted Broad Patent for DABRA Catheter
News | Peripheral Artery Disease (PAD)| August 09, 2017
August 9, 2017 — Ra Medical Systems announced that the United States Patent and Trademark Office (USPTO) has granted
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies| August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
Abbott Initiates XIENCE Short DAPT Clinical Trial
News | Antiplatelet and Anticoagulation Therapies| August 03, 2017
Abbott recently announced the first patient has been enrolled in a clinical study evaluating the short-term use of...
Overlay Init